Anti-CD33-CLL1 CAR-T Cells (ICG415) for the Treatment of Relapsed/Refractory Acute Myeloid Leukemia
Clinical trial NCT07668557 · RECRUITING
Trial details
- NCT number
- NCT07668557
- Sponsor
- iCell Gene Therapeutics
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-10
- Primary completion
- 2028-07-04
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.